Gema Santamaria-Nuñez

5PUBLICATIONS
33CO-AUTHORS
Molecular targetsPredictive and prognostic markersBiologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jan 02, 2026
PM534, a Novel Colchicine Site Tubulin Inhibitor with Broad-Spectrum and Resistance-Overcoming Antitumor Activity.

Pablo Aviles, Marcelo Lima Ribeiro, Maria Jose Guillén

|Dec 05, 2024
Unveiling the Mechanism of Lurbinectedin's Action and Its Potential in Combination Therapies in Small Cell Lung Cancer.

Antonio Calles, Emiliano Calvo, Gema Santamaría Nuñez

|Aug 28, 2024
From Sea Sponge to Clinical Trials: Starting the Journey of the Novel Compound PM742.

Patricia G Cruz, Rogelio Fernández, Raquel Rodríguez-Acebes

|Mar 09, 2022
Promoters of ASCL1- and NEUROD1-dependent genes are specific targets of lurbinectedin in SCLC cells.

Federico Costanzo, Marta Martínez Diez, Gema Santamaría Nuñez

Pageof 1